Patient Safety Information to ensure safe use of HEMLIBRA for treatment of Haemophilia A


Please present the card at visits to doctors, hospital clinics, laboratory professionals or pharmacists to provide information on HEMLIBRA treatment and risks. If you would like this information in a digital format, please talk to your treatment centre about MedWallet, your digital medication passport.

  • Tell your doctor, nurse or pharmacist about any side effect you experience, bothers you or that does not go away. This includes any possible side effects not listed in the package leaflet. The side effects listed in this brochure are not all of the possible side effects that you could experience with HEMLIBRA.
  • Talk to your doctor, nurse or pharmacist if you have any questions, problems or for more information.
  • You can also report side effects to the Centre for Adverse Reactions Monitoring (CARM) at By reporting side effects you can help provide more information on the safety of this medicine.
  • Adverse reactions (side effects) should also be reported at or Roche Medical Information on 0800 276 243.
  • For full information on all possible adverse events please see the New Zealand Data Sheet at

Safety Booklets

Link to Third Party Site

You are about to leave the site to one that is not controlled or developed by Roche Products (New Zealand) Ltd.

Roche does not endorse or control the content of any linked websites and if you click OK, you agree that Roche has no responsibility or duty to you for anything that happens to you as a result. If the linked site is outside New Zealand’s jurisdiction, the information may not be consistent with New Zealand’s legislation, advertising codes or the relevant New Zealand registered Data Sheet. Please refer to the Data Sheet or Consumer Medicine Information on the Medsafe website for product information applicable to New Zealand.

Click OK to continue.